
Investigational Neoantigen Vaccines Target RCC Mutations and Drive Durable T-Cell Activity
Early data with personalized neoantigen vaccines demonstrate their promising immune activation and durable antitumor activity in select patients with kidney cancer, laying the groundwork for further investigation of this treatment approach in the adjuvant …